Reporting
Downloads
Investor updates
Downloads
Investor updates
Downloads
Investor updates
Downloads
Investor updates
Downloads
Investor updates
Downloads
Investor updates
Downloads
Investor updates
Downloads
Investor updates
Downloads
Investor updates
Downloads
Investor updates
Downloads
Investor updates
Downloads
Investor updates
Downloads
Investor updates
Downloads
Investor updates
Downloads
Investor updates

Our reporting

Roche’s non-financial reporting is directed by the Corporate Sustainability Committee and assured by PricewaterhouseCoopers. The data and information collected serves as a guide for reviewing and adjusting the sustainability strategy. We firmly believe that transparent reporting helps us improve our business. We are committed to communicating relevant, clear, balanced and accurate information to our stakeholders.

Stakeholder engagement

Reporting scope

We provide integrated information about Roche’s financial and non-financial performance in our Annual Report , Finance Report as well as in our online report , and cover all regions and divisions from 1 January to 31 December 2021.

The reporting scope is defined and outlined in our Finance Report and there have been no significant changes in scope in 2021 compared to 2020.

Committed to support the UN SDGs

We contribute to a number of the 2030 United Nations Sustainable Development Goals (SDGs) and its 169 specific targets within the sphere of our work. We are particularly pleased to see a dedicated goal on Health (SDG 3). This is important as health plays a crucial role in societal and economic development.

UN Global Compact

Roche has been a signatory to the UN Global Compact since 2021. Our communication on Progress (COP) shows our commitment to making the UNGC and its ten principles part of our strategy, culture and day-to-day operations, and to advancing the broader development goals of the United Nations, in particular the Sustainable Development Goals.

Reporting in accordance with GRI

We have followed the Global Reporting Initiative (GRI) G4 guidelines since 2014, and have transitioned to the GRI Standards in 2017. By using the GRI guidelines, we disclose the most critical impacts of our activities on the environment, society and the economy.

see GRI index

In accordance with the GRI guidelines, we conduct a materiality assessment on key topics that are highly relevant to us and our key stakeholders.

Data collection

GRI and the European Chemical Industry Council’s ( CEFIC ) Responsible Care Reporting Guidelines provide the framework for our reporting. Each year Roche requires all its entities to provide data and information covering economic, social and environmental indicators, which are consolidated at the group level. Specifically, the grants donations and sponsorship (GSD) data collection process is detailed here. In addition, Roche recognises and follows the international standard ISO 26000 guidance on social responsibility. We track our performance against key financial and non-financial indicators.

Performance

External assurance

Our current Annual Report includes an independent assurance report on our non-financial reporting, prepared by PricewaterhouseCoopers AG.

Independent assurance report

We are committed to transparent reporting and we endeavor to drive our economic, social and environmental performance with the same diligence as our financial performance.

Downloads

Downloads

Downloads

Downloads

Downloads

Downloads

Downloads

Downloads

Downloads

Downloads

View IR team contact detail

Investor relations team contacts

Discover more